FDA.reportPublic FDA data

tapentadol 75 MG Oral Tablet

RxCUI
825413
RxNorm name
tapentadol 75 MG Oral Tablet
Display name
tapentadol 75 MG Oral Tablet
Full name
tapentadol 75 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:30

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TAPENTADOLTAPENTADOL HYDROCHLORIDEHikma Pharmaceuticals USA Inc.863f3fd3-1e8d-41b0-855f-8f9a29237cda2026-02-26Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 825413
Tapentadol HydrochlorideTAPENTADOL HYDROCHLORIDEEPIC PHARMA LLCfecd2104-5bf3-47ed-a6f0-5c6ebb0a17b42026-01-28Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 825413
NucyntaTAPENTADOL HYDROCHLORIDECollegium Pharmaceutical, Inc.80938c30-9fe3-4c7d-9d9c-5476638cfb2d2025-12-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 825413

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
fecd2104-5bf3-47ed-a6f0-5c6ebb0a17b4tapentadol 75 MG (as tapentadol hydrochloride) Oral TabletSY9These highlights do not include all the information needed to use TAPENTADOL TABLETS safely and effectively. See full prescribing information for TAPENTADOL TABLETS. TAPENTADOL tablets, for oral use CII Initial U.S. Approval: 200820260128
fecd2104-5bf3-47ed-a6f0-5c6ebb0a17b4tapentadol 75 MG Oral TabletSCD9These highlights do not include all the information needed to use TAPENTADOL TABLETS safely and effectively. See full prescribing information for TAPENTADOL TABLETS. TAPENTADOL tablets, for oral use CII Initial U.S. Approval: 200820260128
fecd2104-5bf3-47ed-a6f0-5c6ebb0a17b4tapentadol 75 MG Oral TabletPSN9These highlights do not include all the information needed to use TAPENTADOL TABLETS safely and effectively. See full prescribing information for TAPENTADOL TABLETS. TAPENTADOL tablets, for oral use CII Initial U.S. Approval: 200820260128
80938c30-9fe3-4c7d-9d9c-5476638cfb2dtapentadol 75 MG Oral TabletSCD7These highlights do not include all the information needed to use NUCYNTA ® TABLETS safely and effectively. See full prescribing information for NUCYNTA ® TABLETS. NUCYNTA ® (tapentadol) tablets for oral use C-II Initial U.S. Approval: 200820251230
80938c30-9fe3-4c7d-9d9c-5476638cfb2dtapentadol 75 MG Oral TabletPSN7These highlights do not include all the information needed to use NUCYNTA ® TABLETS safely and effectively. See full prescribing information for NUCYNTA ® TABLETS. NUCYNTA ® (tapentadol) tablets for oral use C-II Initial U.S. Approval: 200820251230
80938c30-9fe3-4c7d-9d9c-5476638cfb2dtapentadol 75 MG (as tapentadol hydrochloride) Oral TabletSY7These highlights do not include all the information needed to use NUCYNTA ® TABLETS safely and effectively. See full prescribing information for NUCYNTA ® TABLETS. NUCYNTA ® (tapentadol) tablets for oral use C-II Initial U.S. Approval: 200820251230
ad05d6a0-addc-46e9-a5bd-7892b262b090tapentadol 75 MG (as tapentadol hydrochloride) Oral TabletSY5These highlights do not include all the information needed to use NUCYNTA ® TABLETS safely and effectively. See full prescribing information for NUCYNTA ® TABLETS. NUCYNTA ® (tapentadol) tablets for oral use C-II Initial U.S. Approval: 200820181207
ad05d6a0-addc-46e9-a5bd-7892b262b090tapentadol 75 MG Oral TabletSCD5These highlights do not include all the information needed to use NUCYNTA ® TABLETS safely and effectively. See full prescribing information for NUCYNTA ® TABLETS. NUCYNTA ® (tapentadol) tablets for oral use C-II Initial U.S. Approval: 200820181207
ad05d6a0-addc-46e9-a5bd-7892b262b090tapentadol 75 MG Oral TabletPSN5These highlights do not include all the information needed to use NUCYNTA ® TABLETS safely and effectively. See full prescribing information for NUCYNTA ® TABLETS. NUCYNTA ® (tapentadol) tablets for oral use C-II Initial U.S. Approval: 200820181207
863f3fd3-1e8d-41b0-855f-8f9a29237cdatapentadol 75 MG Oral TabletSCD2These highlights do not include all the information needed to use TAPENTADOL TABLETS safely and effectively. See full prescribing information for TAPENTADOL TABLETS. Tapentadol tablets for oral use C-II Initial U.S. Approval: 200820260226
863f3fd3-1e8d-41b0-855f-8f9a29237cdatapentadol 75 MG Oral TabletPSN2These highlights do not include all the information needed to use TAPENTADOL TABLETS safely and effectively. See full prescribing information for TAPENTADOL TABLETS. Tapentadol tablets for oral use C-II Initial U.S. Approval: 200820260226
863f3fd3-1e8d-41b0-855f-8f9a29237cdatapentadol 75 MG (as tapentadol hydrochloride) Oral TabletSY2These highlights do not include all the information needed to use TAPENTADOL TABLETS safely and effectively. See full prescribing information for TAPENTADOL TABLETS. Tapentadol tablets for oral use C-II Initial U.S. Approval: 200820260226
4a6953cd-9d64-4443-b7db-5aef2c81324dtapentadol 75 MG Oral TabletPSN2These highlights do not include all the information needed to use NUCYNTA® safely and effectively. See full prescribing information for NUCYNTA®. NUCYNTA® (tapentadol) immediate-release oral tablets C-II Initial U.S. Approval: 200820100324
4a6953cd-9d64-4443-b7db-5aef2c81324dtapentadol 75 MG Oral TabletSCD2These highlights do not include all the information needed to use NUCYNTA® safely and effectively. See full prescribing information for NUCYNTA®. NUCYNTA® (tapentadol) immediate-release oral tablets C-II Initial U.S. Approval: 200820100324
4a6953cd-9d64-4443-b7db-5aef2c81324dtapentadol 75 MG (as tapentadol hydrochloride) Oral TabletSY2These highlights do not include all the information needed to use NUCYNTA® safely and effectively. See full prescribing information for NUCYNTA®. NUCYNTA® (tapentadol) immediate-release oral tablets C-II Initial U.S. Approval: 200820100324
ba3db17e-5697-46f0-8fb3-dd19e93e1a08tapentadol 75 MG Oral TabletSCD1These highlights do not include all the information needed to use NUCYNTA ® safely and effectively. See full prescribing information for NUCYNTA ® . NUCYNTA ® (tapentadol) immediate-release oral tablets C-II Initial U.S. Approval: 200820100709
ba3db17e-5697-46f0-8fb3-dd19e93e1a08tapentadol 75 MG (as tapentadol hydrochloride) Oral TabletSY1These highlights do not include all the information needed to use NUCYNTA ® safely and effectively. See full prescribing information for NUCYNTA ® . NUCYNTA ® (tapentadol) immediate-release oral tablets C-II Initial U.S. Approval: 200820100709
ba3db17e-5697-46f0-8fb3-dd19e93e1a08tapentadol 75 MG Oral TabletPSN1These highlights do not include all the information needed to use NUCYNTA ® safely and effectively. See full prescribing information for NUCYNTA ® . NUCYNTA ® (tapentadol) immediate-release oral tablets C-II Initial U.S. Approval: 200820100709